Cargando…

Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model

BACKGROUND: The effects of the murine monoclonal anti-PcrV antibody Mab166 on acute lung injury induced by Pseudomonas aeruginosa were analyzed in a rat model. METHODS: Lung injury was induced by the instillation of P. aeruginosa strain PA103 directly into the left lungs of anesthetized rats. One ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faure, Karine, Fujimoto, Junichi, Shimabukuro, David W, Ajayi, Temitayo, Shime, Nobuaki, Moriyama, Kiyoshi, Spack, Edward G, Wiener-Kronish, Jeanine P, Sawa, Teiji
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC194171/ https://www.ncbi.nlm.nih.gov/pubmed/12943554 http://dx.doi.org/10.1186/1476-8518-1-2

Ejemplares similares

TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins
por: Faure, Karine, et al.
Publicado: (2004)

Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review
por: Sawa, Teiji, et al.
Publicado: (2014)

Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against Pseudomonas aeruginosa
por: Wan, Chuang, et al.
Publicado: (2019)

Identification of Small Molecules Blocking the Pseudomonas aeruginosa Type III Secretion System Protein PcrV
por: Sundin, Charlotta, et al.
Publicado: (2021)

Self-assembled ferritin nanoparticles displaying PcrV and OprI as an adjuvant-free Pseudomonas aeruginosa vaccine
por: Li, Yuhang, et al.
Publicado: (2023)

Production of an Antibody Fragment (scFv) Targeting PcrV Protein of Pseudomonas aeruginosa in Fed-Batch Cultivation Mode
por: Karam, Saba, et al.
Publicado: (2021)

Vaccination of mice with hybrid protein containing Exotoxin S and PcrV with adjuvants alum and MPL protects Pseudomonas aeruginosa infections
por: Asadi Karam, Mohammad Reza, et al.
Publicado: (2022)

PopB-PcrV Interactions Are Essential for Pore Formation in the Pseudomonas aeruginosa Type III Secretion System Translocon
por: Kundracik, Emma, et al.
Publicado: (2022)

Protective Effect of DNA Vaccine Encoding Pseudomonas Exotoxin A and PcrV against Acute Pulmonary P. aeruginosa Infection
por: Jiang, Mingzi, et al.
Publicado: (2014)

A Live Salmonella Vaccine Delivering PcrV through the Type III Secretion System Protects against Pseudomonas aeruginosa
por: Aguilera-Herce, Julia, et al.
Publicado: (2019)

Development of a Chimeric Vaccine Against Pseudomonas aeruginosa Based on the Th17-Stimulating Epitopes of PcrV and AmpC
por: Wang, Ying, et al.
Publicado: (2021)

Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa
por: Wang, Xingyun, et al.
Publicado: (2023)

Effect of a Novel Trivalent Vaccine Formulation against Acute Lung Injury Caused by Pseudomonas aeruginosa
por: Inoue, Keita, et al.
Publicado: (2023)

697. Pseudomonas aeruginosa PcrV and Psl, the Molecular Targets of Bispecific Monoclonal Antibody MEDI3902, Are Conserved Among Diverse Hospital Isolates Collected From an International Surveillance Study
por: Tabor, David E
Publicado: (2018)

Modified Needle-Tip PcrV Proteins Reveal Distinct Phenotypes Relevant to the Control of Type III Secretion and Intoxication by Pseudomonas aeruginosa
por: Sato, Hiromi, et al.
Publicado: (2011)

Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models
por: Yang, Feng, et al.
Publicado: (2017)

The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response
por: Sawa, Teiji
Publicado: (2014)

Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria
por: Sato, Hiromi, et al.
Publicado: (2011)

Type III Secretion Protein, PcrV, Impairs Pseudomonas aeruginosa Biofilm Formation by Increasing M1 Macrophage-Mediated Anti-bacterial Activities
por: Yu, Hua, et al.
Publicado: (2020)

Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
por: Fakoor, Mohammad Hadi, et al.
Publicado: (2020)

Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection
por: Li, Peng, et al.
Publicado: (2021)

Type III secretion proteins PcrV and PcrG from Pseudomonas aeruginosa form a 1:1 complex through high affinity interactions
por: Nanao, Max, et al.
Publicado: (2003)

Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance
por: Sawa, Teiji, et al.
Publicado: (2020)

Pseudomonas aeruginosa Type III Secretory Toxin ExoU and Its Predicted Homologs
por: Sawa, Teiji, et al.
Publicado: (2016)

Acute Pneumonia
por: Dotson, Rachel H., et al.
Publicado: (2007)

Wearables alone will not eliminate failure to rescue
por: Wiener-Kronish, Jeanine P., et al.
Publicado: (2022)

Multifunctional Monoclonal Antibody Targeting Pseudomonas aeruginosa Keratitis in Mice
por: Hebert, Wesley, et al.
Publicado: (2020)

Pseudomonas aeruginosa PcrV Enhances the Nitric Oxide-Mediated Tumoricidal Activity of Tumor-Associated Macrophages via a TLR4/PI3K/AKT/mTOR-Glycolysis-Nitric Oxide Circuit
por: Yu, Hua, et al.
Publicado: (2021)

Development of an anti-Pseudomonas aeruginosa therapeutic monoclonal antibody WVDC-5244
por: Horspool, Alexander M., et al.
Publicado: (2023)

Remote Surveillance Technologies: Realizing the Aim of Right Patient, Right Data, Right Time
por: Safavi, Kyan C., et al.
Publicado: (2019)

Chronic pneumonia with Pseudomonas aeruginosa and impaired alveolar fluid clearance
por: Boyer, Sophie, et al.
Publicado: (2005)

Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship
por: Bortolotti, Perrine, et al.
Publicado: (2016)

Immunoglobulin for Treating Bacterial Infections: One More Mechanism of Action
por: Sawa, Teiji, et al.
Publicado: (2019)

Monoclonal antibodies against lipopolysaccharide protect against Pseudomonas aeruginosa challenge in mice
por: Kang, Jason, et al.
Publicado: (2023)

Protective role of murine norovirus against Pseudomonas aeruginosa acute pneumonia
por: Thépaut, Marion, et al.
Publicado: (2015)

Epidemiological survey of serum titers from adults against various Gram-negative bacterial V-antigens
por: Kinoshita, Mao, et al.
Publicado: (2020)

Characterization of a novel mCH3 conjugated anti-PcrV scFv molecule
por: Komijani, Samira, et al.
Publicado: (2021)

Pseudomonas aeruginosa in Chronic Lung Infections: How to Adapt Within the Host?
por: Faure, Emmanuel, et al.
Publicado: (2018)

Necrotizing pneumonia due to Pseudomonas aeruginosa secondary to severe COVID‐19 pneumonia
por: Hirai, Jun, et al.
Publicado: (2023)

Draft Genome Sequences of Two Pseudomonas aeruginosa Multidrug-Resistant Clinical Isolates, PAL0.1 and PAL1.1
por: Grandjean, Teddy, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cr5lhrh0i6bej6h0vi9d024f6j